CORONAVIRUS/Medigen gets funds from global foundation for mix-and-match booster trials

12/02/2021 10:51 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Dec. 2 (CNA) Taiwanese pharmaceutical company Medigen Vaccine Biologics Corp. said Thursday that it has received a US$2.3 million grant from an international foundation to fund trials of its COVID-19 vaccine as a potential booster.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.